Tevogen Bio Holdings Inc. (TVGN) Financials

TVGN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 4.9 million 14.8 million
Dec. 31, 2025 4.4 million 12.6 million
Sept. 30, 2025 4.5 million 12.3 million
June 30, 2025 4.3 million 13.8 million

TVGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -2.7 million 2.8 million
Dec. 31, 2025 -2.2 million 2.4 million
Sept. 30, 2025 -3.6 million 3.2 million
June 30, 2025 -3.2 million 3.2 million

TVGN Net Income

No data available :(

TVGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 692305 1.1 million 1.4 million
Dec. 31, 2025 552372 1.1 million 327740
Sept. 30, 2025 1.0 million 4.4 million 1.5 million
June 30, 2025 685229 4.4 million 1.5 million

TVGN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 3.5 million
Dec. 31, 2025 3.3 million
Sept. 30, 2025 3.9 million
June 30, 2025 3.7 million

TVGN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 3.1 million 2.3 million -
Dec. 31, 2025 64433 2.1 million 2.5 million -
Sept. 30, 2025 4 3.1 million 2.6 million -
June 30, 2025 3 2.7 million 2.7 million -

TVGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 - 85786
Sept. 30, 2025 - 27225
June 30, 2025 - 290784

TVGN

Price: $9.46

52 week price:
4.14
75.50

Earnings Per Share: -6.44 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 37.9 million

Links: